Fatty acid binding protein 1 is related with development of aspirin-exacerbated respiratory disease

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Kim, Tae Hoon ^a   Lee, Ji Yeon ^a   Park, Jong Sook ^a   Park, Sung Woo ^a   Jang, An Soo ^a   Lee, Jae Yong ^a   Byun, Jang Yul ^a   Uh, Soo Taek ^b   Koh, Eun Suk ^a   Chung, Il Yup ^c   Park, Choon Sik ^a  

^a Soonchunhyang University   (South Korea)

^b Soonchunhyang University College of Medicine   (South Korea)

^c Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE 4A1 PRECURSOR; BETA ACTIN; BETAINE HOMOCYSTEINE METHYLTRANSFERASE; BETAINE HOMOCYSTEINE METHYLTRANSFERASE ISOFORM CRA B; CARBAMOYL PHOSPHATE SYNTHASE; CELL PROTEIN; CHAPERONIN; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT RESPONSIVE PROTEIN 12; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70 PROTEIN 9 PRECURSOR; IMMUNOGLOBULIN LIGHT CHAIN; PROTEIN KIAA1361; TRANSKETOLASE; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE GLUCOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; URIDINE TRIPHOSPHATE GLUCOSE 1 PHOSPHATE URIDYLYLTRANSFERASE 2 ISOFORM A; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 609;

ADULT; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASPIRIN TOLERANT ASTHMA; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG DOSE INCREASE; DRUG HYPERSENSITIVITY; EOSINOPHIL; EPITHELIUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MACROPHAGE; MALE; NOSE POLYP; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEOMICS; SMOOTH MUSCLE FIBER; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING; CHEMICALLY INDUCED DISORDER; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; RESPIRATORY TRACT DISEASE;

ASPIRIN; BLOTTING, WESTERN; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FATTY ACID-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; RESPIRATORY TRACT DISEASES; TANDEM MASS SPECTROMETRY;

EID: 79961163865     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022711     Document Type: Article

References (35)

1. Stevenson DD, Szczeklik A, (2006) Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 118: 773-786; quiz 787-778.
2. Szczeklik A, Nizankowska E, Duplaga M, (2000) Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 16: 432-436.
3. Sanak M, Simon HU, Szczeklik A, (1997) Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 350: 1599-1600.
4. Choi JH, Park HS, Oh HB, Lee JH, Suh YJ, et al. (2004) Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase. Hum Genet 114: 337-344.
5. Jinnai N, Sakagami T, Sekigawa T, Kakihara M, Nakajima T, et al. (2004) Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach. Hum Mol Genet 13: 3203-3217.
6. Park BL, Park SM, Park JS, Uh ST, Choi JS, et al. (2010) Association of PTGER gene family polymorphisms with aspirin intolerant asthma in Korean asthmatics. BMB Rep 43: 445-449.
7. Kim SH, Choi JH, Park HS, Holloway JW, Lee SK, et al. (2005) Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma. Clin Exp Allergy 35: 585-590.
8. Park JS, Chang HS, Park CS, Lee JH, Lee YM, et al. (2005) Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics. Pharmacogenet Genomics 15: 483-492.
9. Kopp E, Ghosh S, (1994) Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265: 956-959.
10. Kim BS, Park SM, Uhm TG, Kang JH, Park JS, et al. (2010) Effect of single nucleotide polymorphisms within the interleukin-4 promoter on aspirin intolerance in asthmatics and interleukin-4 promoter activity. Pharmacogenet Genomics 20: 748-758.
11. Perez GM, Melo M, Keegan AD, Zamorano J, (2002) Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6. J Immunol 168: 1428-1434.
12. Sekigawa T, Tajima A, Hasegawa T, Hasegawa Y, Inoue H, et al. (2009) Gene-expression profiles in human nasal polyp tissues and identification of genetic susceptibility in aspirin-intolerant asthma. Clin Exp Allergy 39: 972-981.
13. Stankovic KM, Goldsztein H, Reh DD, Platt MP, Metson R, (2008) Gene expression profiling of nasal polyps associated with chronic sinusitis and aspirin-sensitive asthma. Laryngoscope 118: 881-889.
14. Cheong HS, Park SM, Kim MO, Park JS, Lee JY, et al. (2010) Genome-wide methylation profile of nasal polyps: relation to aspirin hypersensitivity in asthmatics. Allergy In press.
15. Lee SH, Rhim T, Choi YS, Min JW, Kim SH, et al. (2006) Complement C3a and C4a increased in plasma of patients with aspirin-induced asthma. Am J Respir Crit Care Med 173: 370-378.
16. Kowalski ML, (2007) Aspirin-sensitive rhinosinusitis and asthma. Clin Allergy Immunol 19: 147-175.
17. Serhan CN, (2007) Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 25: 101-137.
18. Zimmer JS, Dyckes DF, Bernlohr DA, Murphy RC, (2004) Fatty acid binding proteins stabilize leukotriene A4: competition with arachidonic acid but not other lipoxygenase products. J Lipid Res 45: 2138-2144.
19. Ek BA, Cistola DP, Hamilton JA, Kaduce TL, Spector AA, (1997) Fatty acid binding proteins reduce 15-lipoxygenase-induced oxygenation of linoleic acid and arachidonic acid. Biochim Biophys Acta 1346: 75-85.
20. Coca SG, Yalavarthy R, Concato J, Parikh CR, (2008) Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int 73: 1008-1016.
21. Schachtrup C, Emmler T, Bleck B, Sandqvist A, Spener F, (2004) Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins. Biochem J 382: 239-245.
22. Oh SH, Park SM, Park JS, Jang AS, Lee YM, et al. (2009) Association analysis of peroxisome proliferator-activated receptors gamma gene polymorphisms with asprin hypersensitivity in asthmatics. Allergy Asthma Immunol Res 1: 30-35.
23. Min-man W, Hong S, Zhi-qiang X, Xue-ping F, Chang-qi L, et al. (2009) Differential proteomic analysis of nasal polyps, chronic sinusitis, and normal nasal mucosa tissues. Otolaryngol Head Neck Surg 141: 364-368.
24. Al Badaai Y, DiFalco MR, Tewfik MA, Samaha M, (2009) Quantitative proteomics of nasal mucus in chronic sinusitis with nasal polyposis. J Otolaryngol Head Neck Surg 38: 381-389.
25. Farajzadeh Deroee A, Oweinah J, Naraghi M, Hosemann W, Athari B, et al. (2009) Regression of polypoid nasal mucosa after systemic corticosteroid therapy: a proteomics study. Am J Rhinol Allergy 23: 480-485.
26. Morimoto RI, (2008) Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev 22: 1427-1438.
27. Caldovic L, Tuchman M, (2003) N-acetylglutamate and its changing role through evolution. Biochem J 372: 279-290.
28. Yoon KA, Nakamura Y, Arakawa H, (2004) Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses. J Hum Genet 49: 134-140.
29. Brosnan JT, Brosnan ME, (2006) The sulfur-containing amino acids: an overview. J Nutr 136: 1636S-1640S.
30. Balakumar P, Rohilla A, Krishan P, Solairaj P, Thangathirupathi A, (2010) The multifaceted therapeutic potential of benfotiamine. Pharmacol Res 61: 482-488.
31. Meng M, Geisler M, Johansson H, Harholt J, Scheller HV, et al. (2009) UDP-glucose pyrophosphorylase is not rate limiting, but is essential in Arabidopsis. Plant Cell Physiol 50: 998-1011.
32. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, et al. (2008) Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31: 143-178.
33. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczynska M, Picado C, et al. (2007) EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 62: 1111-1118.
34. Cormican LJ, Farooque S, Altmann DR, Lee TH, (2005) Improvements in an oral aspirin challenge protocol for the diagnosis of aspirin hypersensitivity. Clin Exp Allergy 35: 717-722.
35. Shevchenko A, Wilm M, Vorm O, Mann M, (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68: 850-858.